Tasigna® Lawsuit – News

Tasigna® has been linked to Atherosclerosis and other serious side effects including Amputation, Stroke, Heart Attack, and Death.

Cardiovascular Toxicity Related to Chronic Myeloid Leukemia Medications

Several recent studies have reported vascular toxicity with nilotinib (Tasigna®) (Table 1). In a retrospective multicenter analysis of 179 patients, 11 patients (6.2%) developed peripheral arterial disease (PAD) involving lower limbs. Most striking was the severity of PAD; eight patients required invasive therapy (angioplasty and stent placement), and four patients required amputation.56

READ MORE at Journal of Clinical Oncology

Peripheral artery occlusive disease (PAOD) in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib

The medical journal Leukemia published an article revealing a link between Tasigna® and peripheral artery occlusive disease (PAOD). Results of their study showed that people using Tasigna® were more likely to develop PAOD than those using a competing medication.

READ MORE at Leukemia (Scholarly Journal)

A Potential Explanation for Drug-Induced Vasculopathy In CML

Nilotinib (Tasigna®) appears to cause metabolic changes, including an increase in the fasting glucose level. In addition, vascular adverse events, including progressive atherosclerosis with peripheral arterial occlusive disease (AOD) have been reported in nilotinib-treated CML patients.

READ MORE at Blood (Scholarly Journal)

Tasigna® Claim Survey
Please fill out the survey to see if you could qualify for a claim or call 800-972-5291 to speak with a representative.

Were you or your loved one prescribed Tasigna® to treat your Leukemia?

What year did you START taking Tasigna®?

Which of the following complications did you experience AFTER you started taking Tasigna®?

Prior to taking Tasigna®, were you diagnosed with diabetes, coronary artery disease, high blood pressure, heart attack and/or Stroke?

Have you or your loved one been represented by an attorney or declined for representation by an attorney, concerning Tasigna®?